Ovarian Cancer Surgery in Ahmedabad — Cytoreductive Surgery at EPIC Multispecialty Hospital
Ovarian cancer is the most lethal gynaecological malignancy — the majority of cases present at advanced stage (FIGO III to IV), when cancer has spread throughout the peritoneal cavity, because early-stage ovarian cancer produces no symptoms and there is no effective screening test. The combination of advanced presentation, chemotherapy resistance, and high recurrence rates makes ovarian cancer one of the most challenging cancers to manage — and the quality of primary cytoreductive surgery is one of the most powerful determinants of survival.
At EPIC Multispecialty Hospital, Ahmedabad, ovarian cancer surgery is performed by gynaecological oncologists experienced in complex pelvic and abdominal cytoreductive surgery — including peritoneal stripping, bowel resection, diaphragm peritonectomy, splenectomy, and hepatic resection where required to achieve complete macroscopic tumour clearance (R0 or complete cytoreduction). The evidence is unambiguous: patients with complete cytoreduction — no visible residual disease — have significantly better progression-free and overall survival than those with optimal cytoreduction (under 1cm residual) or suboptimal debulking.
Patients with ovarian cancer from across Gujarat — from Vadodara, Surat, Rajkot, Gandhinagar, Anand, Nadiad, and Bharuch — and from Rajasthan and Madhya Pradesh seek ovarian cancer surgery at EPIC Multispecialty Hospital, Ahmedabad, where the surgical complexity of advanced ovarian cancer cytoreduction is managed by a team with the specific expertise these operations demand.
Ovarian Cancer Surgery at EPIC Multispecialty Hospital, Ahmedabad — Surgical Approach and Cytoreduction
- Primary cytoreductive surgery: Primary cytoreductive surgery — performed at initial diagnosis without preceding chemotherapy — aims to remove all macroscopic tumour from the peritoneal cavity. Standard procedure: total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, pelvic and para-aortic lymphadenectomy, and peritoneal biopsies. Extended cytoreduction for disease spread to the diaphragm, liver surface, spleen, bowel mesentery, and retroperitoneal nodes includes diaphragmatic peritonectomy, liver surface tumour resection, splenectomy, small and large bowel resection with anastomosis, and rectosigmoid resection with colorectal anastomosis or colostomy. At EPIC Multispecialty Hospital, Ahmedabad, we perform extended cytoreductive surgery where it achieves complete macroscopic clearance.
- Interval debulking surgery (IDS): For patients presenting with advanced disease where primary cytoreduction is likely to leave significant residual disease — assessed by CT staging and diagnostic laparoscopy using the Fagotti score to predict cytoreductive completeness — neoadjuvant chemotherapy (NACT) with 3 cycles of carboplatin-paclitaxel followed by interval debulking surgery (IDS) after restaging produces equivalent overall survival to primary cytoreduction in selected patients. IDS after NACT is technically easier (smaller tumour volume, better tissue planes) and carries lower morbidity. The decision between primary cytoreduction and NACT-IDS at EPIC Hospital Ahmedabad is made by the gynaecological oncology tumour board based on imaging, diagnostic laparoscopy score, and patient fitness.
- Complete cytoreduction — the surgical quality benchmark: The most important surgical outcome measure in ovarian cancer is residual disease status after cytoreduction. Complete cytoreduction (CC-0, no visible residual disease) produces median overall survival of 60 to 80 months. Optimal cytoreduction (CC-1, under 1cm residual) produces 40 to 50 months. Suboptimal (over 1cm residual) produces 20 to 30 months. This gradient is steep enough that patients are better served by referral to a centre capable of complete cytoreduction rather than debulking at a centre whose surgical infrastructure or experience does not support the extended procedures required. At EPIC Multispecialty Hospital, Ahmedabad, complete cytoreduction is the target.
- BRCA testing and genetic counselling: Approximately 15 to 20 percent of high-grade serous ovarian cancers are associated with germline BRCA1 or BRCA2 mutations. BRCA testing is recommended for all women with non-mucinous epithelial ovarian cancer at EPIC Hospital Ahmedabad. BRCA-mutated tumours have enhanced sensitivity to platinum-based chemotherapy and are eligible for PARP inhibitor maintenance therapy (olaparib, niraparib) after platinum-sensitive response — significantly extending progression-free survival. Genetic counselling for the patient and family members (cascade testing) is coordinated through our oncogenetics service.
- Early-stage ovarian cancer — staging and conservative surgery: Stage I ovarian cancer — confined to one or both ovaries — is staged surgically with total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, pelvic washings, peritoneal biopsies, and retroperitoneal lymph node sampling. For young women with stage IA grade 1 disease who wish to preserve fertility, fertility-sparing surgery (unilateral salpingo-oophorectomy with comprehensive staging) is oncologically appropriate. Our gynaecological oncology team at EPIC Multispecialty Hospital, Ahmedabad, discusses fertility-preservation options in eligible early-stage patients.
- Recurrent ovarian cancer surgery: At first relapse in platinum-sensitive disease (relapse more than 6 months from last platinum treatment), secondary cytoreduction — particularly for isolated nodular recurrence — improves progression-free survival when complete resection is achievable. The AGO DESKTOP III and SOC-1 trials support secondary cytoreduction in patient-selected for complete resection probability. At EPIC Hospital Ahmedabad, secondary cytoreduction candidates are assessed with imaging, Fagotti laparoscopy score, and AGO score before a recommendation is made.
Ovarian Cancer Surgery in Ahmedabad — What Complete Cytoreduction Requires and Why Patient Referral Matters
The most important thing a woman with advanced ovarian cancer in Ahmedabad can do is ensure her primary cytoreductive surgery is performed by a surgeon and at a centre capable of achieving complete macroscopic clearance. This may sound straightforward — every cancer surgeon aspires to remove all tumour — but the reality is that complete cytoreduction in advanced ovarian cancer requires a specific set of surgical competencies that not every centre or surgeon possesses: the ability to strip peritoneum off the diaphragm without causing pneumothorax; to perform a splenectomy safely in the context of omental disease bulk; to resect liver surface tumour nodules without hepatic bleeding; to perform bowel resection and anastomosis for recto-sigmoid involvement; and to close the abdomen safely after a procedure that may last 6 to 8 hours with significant blood loss.
These are not routine general surgical skills — they are the specific competencies of a gynaecological oncologist who performs a high volume of advanced ovarian cancer cytoreductions regularly, supported by a multi-disciplinary intraoperative team that includes a colorectal surgeon for bowel resection, a hepatobiliary surgeon for liver surface involvement, and an intensive care team for post-operative management. At EPIC Multispecialty Hospital, Ahmedabad, this team exists — and the outcome data for complete versus incomplete cytoreduction justify referring patients to a centre with this capability rather than accepting suboptimal debulking at a centre without it.
For patients in Ahmedabad and Gujarat whose ovarian cancer has been diagnosed but not yet surgically treated — or whose primary surgery elsewhere achieved only partial debulking — a consultation at EPIC Multispecialty Hospital, Ahmedabad, will provide an honest assessment of whether complete cytoreduction is achievable, whether neoadjuvant chemotherapy and interval debulking would be a better strategy, and what the realistic survival expectations are for the specific stage and histological subtype of their tumour.
Know Your Signs
Non-healing oral ulcers or white/red patches
Post-menopausal or abnormal uterine bleeding
Chronic cough, blood in sputum, or breathlessness
Unexpected lumps in the neck, breast, abdomen, or limbs
Sudden weight loss or loss of appetite
Persistent bone pain or swelling
Persistent hoarseness or difficulty swallowing
Change in bowel or bladder habits
Emergency Services
Our dedicated emergency team is available 24/7 to provide immediate medical care and support in critical situations.
Get In Touch
BOOK AN APPOINTMENT
Find Best Cancer Surgein in Ahmedabad
Highly Experienced Onco Surgeon Team
24×7 Critical Care & Oncology Support
Complete cancer care under one roof - screening, diagnosis, treatment, transplant & follow-up
World-class OT facilities with advanced technology like ICG-guided Sentinel Node Biopsy for accurate staging and Image-Guided Surgery for precise tumor removal, ensuring safer, more effective cancer treatment.
Detects lesions <1 cm and predicts malignancy probability—improving early diagnosis.
Qure.ai AI-powered cancer detection
Specialized procedures like CRS, HIPEC & PIPAC for advanced disease
40 bedded ICU & Critical Care Unit
Affordable treatment with high-quality outcomes
Our Team of Expert Onco Surgeons
DR. RIDHAM SHAH
M.S. (General Surgery) Dr. N.B. (Surgical Oncology)
DR. SHALIN SHAH
M.S. (General Surgery) Dr. N.B. (Surgical Oncology)
Talks By Our Onco Surgeons
Oral Cancer Surgery – Dr. Bhavin Vadodariya, Surgical Oncologist and Head and Neck Surgeon
Inspiring Healing: Expert Care by Dr. Rutul Patel & Dr. Jay Kumar Mehta!
Breast Cancer – Dr. Tarang Patel
Talks By Our Onco Surgeons
Breast Cancer – Dr. Tarang Patel
Inspiring Healing: Expert Care by Dr. Rutul Patel & Dr. Jay Kumar Mehta!
Oral Cancer Surgery – Dr. Bhavin Vadodariya, Surgical Oncologist and Head and Neck Surgeon
Frequently Asked Questions — Ovarian Cancer Surgery in Ahmedabad
What is cytoreductive surgery for ovarian cancer?
Cytoreductive surgery (debulking) aims to remove all macroscopic tumour from the peritoneal cavity and abdominal organs — total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, lymphadenectomy, and extended resections of peritoneal, diaphragmatic, bowel, liver surface, and splenic disease where present. Complete cytoreduction (no visible residual disease) is the strongest prognostic factor for ovarian cancer survival. At EPIC Multispecialty Hospital, Ahmedabad, complete cytoreduction is the surgical goal.
What is the difference between primary cytoreduction and interval debulking?
Primary cytoreduction is surgery at initial diagnosis before chemotherapy. Interval debulking surgery (IDS) is performed after 3 cycles of neoadjuvant chemotherapy — reserved for patients where primary complete cytoreduction is not achievable or where initial disease burden is very high. Both approaches are used at EPIC Hospital Ahmedabad; the decision is made by the tumour board based on imaging, diagnostic laparoscopy, and patient fitness.
What is the survival for advanced ovarian cancer after surgery?
Complete cytoreduction (no residual disease) with subsequent chemotherapy achieves median overall survival of 60 to 80 months for high-grade serous ovarian cancer. Optimal cytoreduction (under 1cm residual) achieves 40 to 50 months. Suboptimal debulking achieves 20 to 30 months. These differences — entirely attributable to surgical quality — are the strongest argument for referral to a high-volume complete cytoreduction centre.
What is BRCA testing and should I have it for ovarian cancer?
Yes. BRCA1 and BRCA2 germline testing is recommended for all women with non-mucinous epithelial ovarian cancer. Approximately 15 to 20 percent of high-grade serous ovarian cancers are BRCA-mutated — conferring better platinum sensitivity and eligibility for PARP inhibitor maintenance therapy (olaparib, niraparib). Testing is arranged through our oncogenetics service at EPIC Multispecialty Hospital, Ahmedabad.
Can ovarian cancer surgery preserve fertility?
For stage IA grade 1 epithelial ovarian cancer in young women who strongly wish to preserve fertility, unilateral salpingo-oophorectomy with comprehensive surgical staging is oncologically appropriate — preserving the uterus and contralateral ovary. This is a carefully selected group; fertility-sparing surgery is not appropriate for higher-risk histologies, bilateral disease, or advanced stage.
Is secondary surgery for recurrent ovarian cancer worthwhile?
In carefully selected patients with platinum-sensitive first relapse and isolated resectable disease, secondary cytoreduction improves progression-free survival. The AGO DESKTOP III and SOC-1 trials support secondary surgery when complete resection probability is high (positive AGO score). Our team at EPIC Multispecialty Hospital, Ahmedabad, assesses secondary cytoreduction candidates with imaging and diagnostic laparoscopy before recommending reoperation.
Is EPIC Hospital Ahmedabad experienced in advanced ovarian cancer surgery?
EPIC Multispecialty Hospital, Ahmedabad, performs advanced ovarian cancer cytoreduction — including diaphragmatic peritonectomy, splenectomy, bowel resection, and liver surface tumour resection — within a gynaecological oncology programme that includes multi-disciplinary tumour board review, BRCA testing, and PARP inhibitor maintenance access. Patients from across Gujarat and neighbouring states receive ovarian cancer care at our centre.
What is the cost of ovarian cancer surgery in Ahmedabad at EPIC Hospital?
Ovarian cancer cytoreductive surgery costs at EPIC Multispecialty Hospital, Ahmedabad, vary based on the extent of surgery — standard cytoreduction versus extended procedures involving bowel resection, splenectomy, or diaphragmatic peritonectomy. Extended cytoreduction carries higher costs based on operative time, multi-specialty involvement, and ICU stay. Transparent pricing and insurance pre-authorisation assistance are available. Contact our patient services team for current pricing.
Ovarian Cancer Surgery in Ahmedabad — EPIC Multispecialty Hospital
Ovarian cancer surgery at EPIC Multispecialty Hospital, Ahmedabad, is performed with complete cytoreduction as the surgical goal — because the evidence is unambiguous that no residual disease at the end of surgery is the single most powerful determinant of ovarian cancer survival. Our gynaecological oncology team has the surgical competence and institutional support to achieve this goal for patients who are appropriately staged and fit for surgery.
Book an ovarian cancer surgery consultation online, call EPIC Multispecialty Hospital Ahmedabad today, WhatsApp your CT staging and CA-125 results for initial tumour board review, or visit us directly — and get ovarian cancer surgery from a team that targets complete cytoreduction, not just debulking.